4basebio Seeks Shareholder Approval for Capital Raise of at Least £15 Million
4basebio shareholders will vote November 6, 2026, on share issuance authorities for a proposed capital raise of at least £15 million. Resolutions would authorize directors to allot new ordinary shares and disapply statutory pre-emption rights for the placing, subscription and retail offer. New shares would be issued at